Bio-Techne
TECH
#1895
Rank
A$15.83 B
Marketcap
A$100.95
Share price
-0.06%
Change (1 day)
23.66%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): A$1.05

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$0.99. In 2025 the company made an earnings per share (EPS) of A$0.73 a decrease over its 2024 EPS that were of A$1.40.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.0544.1%
2025A$0.73-48%
2024A$1.40-29.58%
2023A$1.98-14.97%
2022A$2.3324.16%
2021A$1.8817.98%
2020A$1.59-10.94%
2019A$1.79101.57%
2018A$0.89-16.99%
2017A$1.0745.02%
2016A$0.74-20.97%
2015A$0.93-14.97%
2014A$1.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.44 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$4.61 364.79%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$11.95 1,105.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.25 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.72 174.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
A-$0.29-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$8.53 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA